GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (NYSE:MRK) » Definitions » Price-to-Free-Cash-Flow

Merck (MRK) Price-to-Free-Cash-Flow

: 35.02 (As of Today)
View and export this data going back to 1949. Start your Free Trial

As of today (2024-04-19), Merck's share price is $125.87. Merck's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.59. Hence, Merck's Price-to-Free-Cash-Flow Ratio for today is 35.02.

The historical rank and industry rank for Merck's Price-to-Free-Cash-Flow or its related term are showing as below:

MRK' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 11.79   Med: 21.92   Max: 39.38
Current: 34.99

During the past 13 years, Merck's highest Price-to-Free-Cash-Flow Ratio was 39.38. The lowest was 11.79. And the median was 21.92.

MRK's Price-to-Free-Cash-Flow is ranked worse than
64.11% of 496 companies
in the Drug Manufacturers industry
Industry Median: 21.17 vs MRK: 34.99

Merck's Free Cash Flow per Share for the three months ended in Dec. 2023 was $-0.29. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $3.59.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Merck was -38.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 16.10% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 7.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 4.50% per year.

During the past 13 years, Merck's highest 3-Year average Free Cash Flow per Share Growth Rate was 45.60% per year. The lowest was -31.50% per year. And the median was 7.50% per year.


Merck Price-to-Free-Cash-Flow Historical Data

The historical data trend for Merck's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.22 34.03 20.13 19.18 30.37

Merck Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.18 24.03 27.10 19.90 30.37

Competitive Comparison

For the Drug Manufacturers - General subindustry, Merck's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck Price-to-Free-Cash-Flow Distribution

For the Drug Manufacturers industry and Healthcare sector, Merck's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Merck's Price-to-Free-Cash-Flow falls into.



Merck Price-to-Free-Cash-Flow Calculation

Merck's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=125.87/3.594
=35.02

Merck's Share Price of today is $125.87.
Merck's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.59.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Merck  (NYSE:MRK) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Merck Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Merck's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Executives
Johannes Jacobus Oosthuizen officer: SVP, U.S. Market 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Richard R. Deluca officer: EVP&Pres, Merck Animal Heallth 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Steven Mizell officer: EVP,Human Resources 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Joseph Romanelli officer: President, Human Health Int?l 126 EAST LINCOLN AVENUE, RAHWAY NJ 07065
Rita A Karachun officer: Sr. VP Fince-Global Controller 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Jennifer Zachary officer: EVP, General Counsel 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Michael Williams officer: EVP,Chief Info&Digital Officer MERCK & CO., INC., 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Robert M Davis officer: Evp, Global Svcs & CFO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Sanat Chattopadhyay officer: Exe V-P & Pres. MMD 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Kenneth C Frazier officer: Chairman, President & CEO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Chirfi Guindo officer: Chief Marketing Officer C/O BIOGEN INC., 225 BINNEY ST., CAMBRIDGE MA 02142
Baker Douglas M Jr director 370 WBASHA ST NORTH, ST PAUL MN 55102
Arpa Garay officer: SVP Human Health Global Mktg. 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Caroline Litchfield officer: EVP & CFO 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Julie L. Gerberding officer: EVP Strat Comm, GI Pub Policy 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033

Merck (MRK) Headlines